UCSF’s Chancellor, Susan Desmond-Hellmann, MD, MPH, was selected by FORBES as one of its 7 Most Powerful Innovators of 2009. You can read the story here. According to the article, Desmond-Hellmann’s most influential innovations were the blockbuster cancer drugs Avastin and Herceptin.
Susan Desmond-Hellmann, a physician and cancer researcher, is a hero to legions of cancer patients. While president of product development at Genentech from 2004 to April 2009, she played an integral role in the selection, testing and development of Avastin, a colon cancer drug with annual sales of $9 billion, and Herceptin, a breast cancer drug with sales of $7.8 billion. In August 2009 she became the chancellor of UCSF, a powerhouse in medical research, where she aims to continue fostering innovation in health care and science.